145 related articles for article (PubMed ID: 38675387)
1. Trichostatin C Synergistically Interacts with DNMT Inhibitor to Induce Antineoplastic Effect via Inhibition of Axl in Bladder and Lung Cancer Cells.
Wang C; Lei L; Xu Y; Li Y; Zhang J; Xu Y; Si S
Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675387
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C).
Maxhimer JB; Reddy RM; Zuo J; Cole GW; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):53-63. PubMed ID: 15632825
[TBL] [Abstract][Full Text] [Related]
3. Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1.
Wang C; Hamacher A; Petzsch P; Köhrer K; Niegisch G; Hoffmann MJ; Schulz WA; Kassack MU
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32028599
[TBL] [Abstract][Full Text] [Related]
4. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
5. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
Jeon HG; Yoon CY; Yu JH; Park MJ; Lee JE; Jeong SJ; Hong SK; Byun SS; Lee SE
J Urol; 2011 Nov; 186(5):2084-93. PubMed ID: 21944112
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors.
Yuan Z; Sun Q; Li D; Miao S; Chen S; Song L; Gao C; Chen Y; Tan C; Jiang Y
Eur J Med Chem; 2017 Jul; 134():281-292. PubMed ID: 28419930
[TBL] [Abstract][Full Text] [Related]
7. Silibinin synergizes with histone deacetylase and DNA methyltransferase inhibitors in upregulating E-cadherin expression together with inhibition of migration and invasion of human non-small cell lung cancer cells.
Mateen S; Raina K; Agarwal C; Chan D; Agarwal R
J Pharmacol Exp Ther; 2013 May; 345(2):206-14. PubMed ID: 23461975
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibitor trichostatin A and autophagy inhibitor chloroquine synergistically exert anti-tumor activity in H-ras transformed breast epithelial cells.
Gao L; Sun X; Zhang Q; Chen X; Zhao T; Lu L; Zhang J; Hong Y
Mol Med Rep; 2018 Mar; 17(3):4345-4350. PubMed ID: 29344672
[TBL] [Abstract][Full Text] [Related]
9. Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene expression.
Luszczek W; Cheriyath V; Mekhail TM; Borden EC
Mol Cancer Ther; 2010 Aug; 9(8):2309-21. PubMed ID: 20682643
[TBL] [Abstract][Full Text] [Related]
10. EZH2 and histone deacetylase inhibitors induce apoptosis in triple negative breast cancer cells by differentially increasing H3 Lys
Huang JP; Ling K
Oncol Lett; 2017 Nov; 14(5):5735-5742. PubMed ID: 29113202
[TBL] [Abstract][Full Text] [Related]
11. The Roles and Regulatory Mechanisms of Tight Junction Protein Cingulin and Transcription Factor Forkhead Box Protein O1 in Human Lung Adenocarcinoma A549 Cells and Normal Lung Epithelial Cells.
Ishii D; Shindo Y; Arai W; Konno T; Kohno T; Honda K; Miyajima M; Watanabe A; Kojima T
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338691
[TBL] [Abstract][Full Text] [Related]
12. Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Niegisch G; Knievel J; Koch A; Hader C; Fischer U; Albers P; Schulz WA
Urol Oncol; 2013 Nov; 31(8):1770-9. PubMed ID: 22944197
[TBL] [Abstract][Full Text] [Related]
13. Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment.
Yang Y; Zhao Y; Liao W; Yang J; Wu L; Zheng Z; Yu Y; Zhou W; Li L; Feng J; Wang H; Zhu WG
Neoplasia; 2009 Apr; 11(4):313-24. PubMed ID: 19308286
[TBL] [Abstract][Full Text] [Related]
14. Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells.
Billam M; Sobolewski MD; Davidson NE
Breast Cancer Res Treat; 2010 Apr; 120(3):581-92. PubMed ID: 19459041
[TBL] [Abstract][Full Text] [Related]
15. Development of a versatile DNMT and HDAC inhibitor C02S modulating multiple cancer hallmarks for breast cancer therapy.
Yuan Z; Chen S; Gao C; Dai Q; Zhang C; Sun Q; Lin JS; Guo C; Chen Y; Jiang Y
Bioorg Chem; 2019 Jun; 87():200-208. PubMed ID: 30901675
[TBL] [Abstract][Full Text] [Related]
16. Azacitidine, as a DNMT Inhibitor Decreases hTERT Gene Expression and Telomerase Activity More Effective Compared with HDAC Inhibitor in Human Head and Neck Squamous Cell Carcinoma Cell Lines.
Atri S; Nasoohi N; Hodjat M
Curr Mol Pharmacol; 2021; 14(1):60-67. PubMed ID: 32394848
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic effects of the natural flavonolignan silibinin on colon adenocarcinoma cells and their derived metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Oncol Lett; 2013 Apr; 5(4):1273-1277. PubMed ID: 23599778
[TBL] [Abstract][Full Text] [Related]
18. The interaction of histone deacetylase inhibitors and DNA methyltransferase inhibitors in the treatment of human cancer cells.
Zhu WG; Otterson GA
Curr Med Chem Anticancer Agents; 2003 May; 3(3):187-99. PubMed ID: 12769777
[TBL] [Abstract][Full Text] [Related]
19. A novel class I histone deacetylase inhibitor, I-7ab, induces apoptosis and arrests cell cycle progression in human colorectal cancer cells.
Yang L; Liang Q; Shen K; Ma L; An N; Deng W; Fei Z; Liu J
Biomed Pharmacother; 2015 Apr; 71():70-8. PubMed ID: 25960218
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B.
Liu N; Zhao LJ; Li XP; Wang JL; Chai GL; Wei LH
Chin Med J (Engl); 2012 Sep; 125(18):3273-8. PubMed ID: 22964322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
